| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.78▼ | 1.79▼ | 1.79▼ | 1.86▼ | 1.88▼ |
| MA10 | 1.78▼ | 1.80▼ | 1.81▼ | 1.90▼ | 2.01▼ |
| MA20 | 1.80▼ | 1.81▼ | 1.85▼ | 1.95▼ | 2.30▼ |
| MA50 | 1.82▼ | 1.87▼ | 1.88▼ | 2.15▼ | 1.53▲ |
| MA100 | 1.87▼ | 1.91▼ | 1.94▼ | 2.55▼ | 1.32▲ |
| MA200 | 1.89▼ | 1.95▼ | 1.97▼ | 1.79▼ | 17.49▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.002▼ | -0.002▼ | -0.006▼ | -0.009▼ | -0.146▼ |
| RSI | 26.812▼ | 25.894▼ | 27.848▼ | 37.263▼ | 47.064▼ |
| STOCH | 8.095▼ | 7.197▼ | 5.219▼ | 17.797▼ | 9.714▼ |
| WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -100.000▼ | -97.297▼ |
| CCI | -166.026▼ | -199.626▼ | -149.951▼ | -160.932▼ | -86.792 |
|
Friday, March 20, 2026 04:59 PM
Genprex, Inc. is a clinical-stage gene therapy company, which engages in the development of therapies for patients with cancer and diabetes. The company product is REQORSA immunogen therapy drug for ...
|
|
Wednesday, March 18, 2026 04:27 AM
Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced ...
|
|
Tuesday, March 10, 2026 12:00 AM
AUSTIN, Texas, March 10, 2026 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 30/03/26 | 1.84 | 1.84 | 1.76 | 1.76 | 220,215 |
| 27/03/26 | 1.89 | 1.89 | 1.81 | 1.82 | 171,019 |
| 26/03/26 | 1.91 | 1.93 | 1.87 | 1.88 | 122,368 |
| 25/03/26 | 1.92 | 1.97 | 1.8801 | 1.94 | 197,606 |
| 24/03/26 | 1.89 | 1.92 | 1.85 | 1.89 | 175,785 |
| 23/03/26 | 1.86 | 1.959 | 1.8501 | 1.91 | 211,350 |
| 20/03/26 | 1.94 | 1.9595 | 1.83 | 1.88 | 237,851 |
| 19/03/26 | 1.95 | 1.95 | 1.8601 | 1.92 | 293,435 |
| 18/03/26 | 2.07 | 2.0805 | 1.98 | 2.01 | 767,830 |
| 17/03/26 | 2.08 | 2.1099 | 1.99 | 2.02 | 246,955 |
|
|
||||
|
|
||||
|
|